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9 Abstract
10 Purpose Previous research has shown a link between
11 treatment satisfaction and global psychopathology in dif-
12 ferent groups of psychiatric patients. However, neither the
13 relationship between treatment satisfaction and the sub-
14 syndromes of global psychopathology nor their temporal
15 ordering have been explored.
16 Methods Participants admitted involuntarily to psychiat-
17 ric wards in the UK and diagnosed with psychotic disorders
18 (N = 232) were included. Treatment satisfaction and psy-
19 chopathological sub-syndromes (i.e., manic excitement,
20 anxiety-depression, negative symptoms, positive symp-
21 toms) were measured within 1 week and at 1 month after
22 admission.
23 Results Repeated measures ANOVAs showed that higher
24 treatment satisfaction is associated with lower scores on the
25 manic excitement, anxiety-depression and positive symp-
26 tom sub-syndromes, while no significant association was
27 found for negative symptoms. However, cross-lagged panel
28 analyses showed that treatment satisfaction predicted
29 change only in positive symptoms while none of the paths
30 from the relevant sub-syndromes to treatment satisfaction
31 was significant.
32 Conclusion Treatment satisfaction can be regarded as
33 an antecedent of changes in positive symptoms only.
34These results underline the importance of examining psy-
35chopathological sub-syndromes separately as they may
36relate differentially to other important correlates of
37psychoses.
38
39Keywords Treatment satisfaction 
40BPRS sub-syndromes  Psychoses
41Introduction
42Treatment satisfaction refers to patients’ perceptions con-
43cerning their satisfaction and appropriateness of their
44treatment [25]. Satisfaction with treatment is critical to
45treatment adherence [9] and among the most widely
46explored patient-reported outcomes [18]. A link between
47treatment satisfaction, assessed within a maximum of
483 days after admission and global psychopathology is
49clearly established with higher satisfaction associated with
50more favourable outcomes [6, 24, 25]. Involuntary legal
51status has consistently been identified as a predictor of
52lower satisfaction [10] when compared to patients with
53voluntary admission status and among involuntary patients
54perceived coercion has been identified as an antecedent of
55treatment satisfaction [14]. Thus, the targeting of involun-
56tary patients’ satisfaction is of clinical relevance, but also an
57important ethical issue, as these patients cannot discontinue
58their treatment even when they are displeased with it [14].
59Does treatment satisfaction influence symptom change
60or does symptom change influence treatment satisfaction or
61both? Theoretically, it is usually assumed that higher
62treatment satisfaction is linked to more symptom
63improvement while lower satisfaction is linked to no
64improvement or even a deterioration of symptoms. For
65example, research has shown higher treatment satisfaction
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66 to predict lower global psychopathology among patients
67 with a range of psychiatric diagnoses [6, 24, 25]. None-
68 theless, satisfaction has also been modelled as an outcome.
69 For example, Katsakou et al. [14] showed that patients who
70 perceived less coercion at admission and during hospital
71 treatment and patients with more symptom improvement
72 expressed higher treatment satisfaction, see Bjorngaard
73 et al. [4] and Shiva et al. [33]. As described by Burkholder
74 and Harlow [7] structural equation models that examine
75 cross-lagged time paths between variables can help to
76 determine their temporal ordering. If cross-lagged paths
77 from both treatment satisfaction to symptoms and from
78 symptoms to treatment satisfaction were statistically sig-
79 nificant, a reciprocal association between the constructs
80 would be suggested. However, if only the path from
81 treatment satisfaction to symptoms is statistically signifi-
82 cant, it may be concluded that treatment satisfaction pre-
83 cedes symptoms and not the other way round. Conversely,
84 if only the path from symptoms to treatment satisfaction is
85 significant, symptoms may be seen as an antecedent of
86 treatment satisfaction.
87 These studies exploring treatment satisfaction have used
88 global psychopathology as the criterion. However, among
89 patients with psychotic disorders, global measures of psy-
90 chopathology comprise at least four interpretable sub-
91 syndromes, namely manic excitement, anxiety-depression,
92 negative symptoms and positive symptoms, which may be
93 influenced by separate processes and aetiologies [30].
94 Citing Lachar et al. [15] and Van der Does et al. [34],
95 Shafer [32] advocates examination of these sub-syndromes
96 independently, arguing that using global scores may mask
97 important treatment effects and specific areas of symptom
98 change. Nonetheless, due to the dearth of research on sub-
99 syndromes, specific mechanisms and therefore hypotheses
100 for each sub-syndrome cannot be specified. However, in
101 general, admission onto a psychiatric ward is expected to
102 promote clinical improvement including symptom out-
103 comes [3].
104 Aims and hypotheses
105 The relationship between subjective treatment satisfaction
106 and the facets of global psychopathology have not been
107 explored. Moreover, the direction of the association
108 between treatment satisfaction and psychopathological
109 symptoms has not been tested. A longitudinal design,
110 where both treatment satisfaction and psychopathological
111 sub-syndromes are measured repeatedly across time can
112 facilitate exploration of these questions.
113 Following on from this, three hypotheses were tested:
114 i) Patients with higher treatment satisfaction during the
115 first week of admission will report lower scores on the
116manic excitement, anxiety-depression, negative and
117positive sub-syndromes overall (i.e., between the first
118week of admission and 1 month post admission) than
119those with lower treatment satisfaction.
120ii) In a cross-lagged panel design with latent variables,
121higher treatment satisfaction will predict symptom
122improvement between the first week of admission and
1231 month post-admission.
124iii) In a cross-lagged panel design with latent variables,
125fewer symptoms will predict higher satisfaction with
126treatment between the first week of admission and
1271 month post-admission.
128Method
129Participants
130All potential participants had been admitted involuntarily
131to a psychiatric ward in the UK between July 2003 and July
1322005 and were recruited for a larger study for which
133detailed inclusion criteria and recruitment process have
134been described elsewhere [26]. Data collection for the
135initial study was approved by the multicentre research
136ethics committee and all participants gave written informed
137consent to take part. Compared to all eligible patients,
138participants interviewed at baseline were more likely to be
139younger and more likely to be male [cf., 26]. Of the 778
140patients interviewed at baseline, only those diagnosed with
141schizophrenia or other psychosis, according to the ICD-10
142categories (i.e., F20-29) were included (N = 383). A mean
143age of 35.91 (±10.94) was reported and 276 (72%) of the
144participants were male.
145Measures
146In baseline interviews, participants were asked to provide
147socio-demographic information including ethnicity (the
148United Kingdom census 2001 categories collapsed into 2
149categories: white versus ethnic minority), and education (4
150categories: no qualification, GCSE grades A–C, ‘A’ level
151or equivalent, and degree). Information on the total length
152of stay (in days) was also collected from medical records.
153Measures of treatment satisfaction and psychopathological
154sub-syndromes were each measured within 1 week and at
1551 month post-admission. For each construct, multi-item
156scale scores were computed by averaging participants’
157responses across the relevant items.
158The Client’s Assessment of Treatment Scale (CAT) was
159used to assess treatment satisfaction [12, 25] which has
160been used in studies with psychiatric inpatients. The scale
161assesses patients’ subjective satisfaction and perceptions of
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162 appropriateness of their treatment using 7 items (e.g., ‘‘Do
163 you believe you are receiving the right treatment/care for
164 you here?’’, ‘‘Are relations with other staff members
165 pleasant for you?’’, ‘‘Does your psychiatrist understand you
166 and is he/she engaged in your treatment/care?’’). Each item
167 is rated on a 11-point Lickert-type scale that ranges from 0
168 ‘not at all’ to 10 ‘yes entirely’ (M = 5.51 ± 2.77 and
169 6.05 ± 2.61 at week 1 and 1 month, respectively).
170 Psychopathological symptoms were researcher rated
171 using the 24-item Brief Psychiatric Rating Scale (BPRS)
172 [35]. Items assess symptom severity on 7-point Likert-type
173 scales with end points that range from ‘not present’ to
174 ‘extremely severe’. Sub-syndromes were indexed using
175 a factor analytic solution of the BPRS among patients
176 with schizophrenia living in the UK [24]. Manic excite-
177 ment (M = 2.10 ± 0.61 and 1.56 ± 0.56 at week 1 and
178 1 month, respectively) was assessed by 9 items (e.g.,
179 hostility, elevated mood), anxiety/depression (M = 2.28 ±
180 0.92 and 2.03 ± 0.88 at week 1 and 1 month, respectively)
181 by 6 items (e.g., somatic concern, anxiety), negative
182 symptoms (M = 1.79 ± 0.88 and 1.63 ± 0.72 at week 1
183 and 1 month, respectively) by 4 items (e.g., disorientation,
184 blunted affect) and positive symptoms (M = 3.18 ± 1.22
185 and 2.20 ± 1.22 at week 1 and 1 month, respectively)
186 using 5 items (e.g., grandiosity, suspiciousness).
187 Analytic strategy
188 Prior to testing the study hypotheses, listwise deletion
189 procedures were used to account for missing data. Thus, in
190 order to assess the representative of our samples t test and
191 v2 analyses were conducted to compare those eligible for
192 the study (N = 383) and participants for whom complete
193 data were available at both points of time (N = 232).
194 Following Luszczynska et al. [16] the hypotheses were
195 tested in 3 analytic steps. First, correlations between the
196 variables were examined. Second, repeated measures
197 analyses of variance across two time points with treatment
198 satisfaction as a between subjects factor (two levels) was
199 used to examine the association between initial treatment
200 satisfaction and each sub-syndrome over time (hypothesis
201 1). Third, a two-step structural equation model (SEM) [1]
202 was used to assess the temporal ordering of treatment
203 satisfaction and each sub-syndrome (hypotheses 2 and 3).
204 The EQS 6 programme [3] was used to test the temporal
205 ordering of treatment satisfaction and each sub-syndrome
206 using the maximum likelihood method for all analyses. A
207 two wave cross-lagged panel model with a 3-week time lag
208 was estimated. A two-step approach to SEM was used to
209 assess the validity and reliability of the constructs before
210 their use in the structural model [1].
211 In the measurement models, treatment satisfaction and
212 the focal sub-syndrome at both time points were modelled
213simultaneously in a single model. Ideally, parameter
214loadings for each separate item on the corresponding latent
215factors would be estimated. However, the size of the
216sample was too small for the number of estimated param-
217eters that such a model would produce, so an item par-
218celling strategy [2] was adopted. Specifically, we created
219three indicators for measures of treatment satisfaction and
220each psychopathological sub-syndrome (at each time point)
221using randomly selected item parcels. The same items were
222included in the parcels at each time point (to ensure that the
223nature of the constructs did not change over time). Refer-
224ence indicators for each latent variable were created by
225fixing the highest indicator’s loading to 1 and as is the
226usual case in confirmatory factor analysis, the latent con-
227structs were allowed to co-vary. Error terms across time
228points for the same indicator were allowed to co-vary,
229where the Lagrange multiplier test indicated that this would
230lead to a statistically significant improvement in model fit
231[21].
232Subsequent path models examined crossover paths
233between satisfaction and the focal sub-syndrome. Specifi-
234cally, the association between treatment satisfaction during
235week 1 of admission (time 1) and the focal sub-syndrome
236at 1 month post-admission (time 2) was compared to the
237relevant association between the focal sub-syndrome dur-
238ing week 1 of admission (time 1) and treatment satisfaction
239measured at 1 month post-admission (time 2). Auto-
240regression coefficients were also specified to control for
241covariance stability between the same constructs over time.
242As the chi-square goodness of fit statistic is sensitive to
243sample size [17] additional recommended indices for
244goodness of fit and cutoffs [11] were used to evaluate the
245adequacy of the models. Specifically, in addition to the v2
246test statistic, the comparative fit index (CFI), non-normed
247fit index (NNFI) and the root-mean square error of
248approximation (RMSEA) are reported. A non-significant v2
249value (p[ 0.05), CFI and NNFI values of 0.90 (or above)
250and a RMSEA of 0.08 (or lower) reflect adequate model fit.
251Results
252Comparison between participants eligible for the study
253(N = 383) and participants for whom complete data were
254available at both time points (N = 232) showed that these
255groups differed neither in gender, age, ethnicity, education
256and length of stay. Table 1 shows the corresponding
257descriptive statistics and frequencies.
258Table 2 presents the correlations between the study
259variables. Higher treatment satisfaction measured during
260week 1 was associated with lower global psychopathology,
261manic excitement, anxiety-depression and positive symp-
262toms at both time points (r range from -0.12 to -0.19).
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263 Contrary to expectation, lower treatment satisfaction dur-
264 ing week 1 was associated with fewer negative symptoms
265 although this did not reach a conventional level of statis-
266 tical significance. Neither global psychopathology nor the
267 four sub-syndromes measured within week 1 were associ-
268 ated with treatment satisfaction at 1 month (r range from
269 -0.06 to 0.05). These results support our first hypothesis
270 for manic excitement, anxiety-depression and positive sub-
271syndromes and indicate that treatment satisfaction precedes
272symptoms (hypotheses 2) rather than the reverse temporal
273hypothesis (hypothesis 3).
274Changes in symptoms over time depending
275on treatment satisfaction
276Repeated measures analyses of variance across two time
277points were conducted for each of the four sub-syndromes
278with treatment satisfaction (measured during week 1) as a
279between-subjects factor (two levels). For this analyses,
280treatment satisfaction scores were standardised and par-
281ticipants scoring above (N = 113) and below zero
282(N = 119), respectively, were categorised into high- and
283low-satisfaction groups.
284The mean score for each sub-syndrome at high and low
285levels of satisfaction are shown in Fig. 1. Each sub-syn-
286drome changed statistically significantly over time, reduc-
287ing from week 1 to 1 month post-admission, F(1,
288230) = 149.80 (r = 0.63), 22.69 (r = 0.30), 10.67
289(r = 0.21) and 129.21 (r = 0.60) (all p\ 0.01), respec-
290tively, for manic excitement, anxiety-depression, negative
291symptoms and positive symptoms. With exception of neg-
292ative symptoms, F(1, 230) = 2.52, p[ 0.05 (r = 0.10),
293patients with higher treatment satisfaction reported fewer
294symptoms overall (i.e., across both time points), F(1,
295230) = 4.74, (r = 0.14), 3.99 (r = 0.13) and 5.59
Table 1 Descriptive statistics comparing patients at baseline and
those with complete data at 1 month
Baseline 1 month
N = 383 N = 232
Male
N (%) 72 72
Age on admission
Mean (SD) 35.91 (10.95) 35.84 (11.47)
Ethnicity
White (%) 63 63
Education
No qualifications (%) 31 30
A–C GCSEs (%) 24 25
‘A’ level or equivalent (%) 36 36
Degree (%) 9 10
Length of stay
Mean (SD) 88.91 (84.09) 94.72 (85.42)
Table 2 Correlations among the study variables during week 1 (T1) and 1 month (T2) post involuntary admission for patients with psychoses
T-sat
T1
T-sat
T2
BPRS
T1
BPRS
T2
Manic
T1
Manic T2 Anx-dep
T1
Anx-dep
T2
Negative
T1
Negative
T2
Positive
T1
Positive
T2
T-sat T1 0.52** -0.19** -0.15* -0.18** -0.12*** -0.15* -0.14* 0.09 0.11 -0.15* -0.17*
T-sat T2 -0.02 -0.29** 0.02 -0.23** -0.06 -0.20** 0.05 -0.04 -0.05 0.25**
BPRS T1 0.51** 0.69** 0.29** 0.55** 0.38** 0.40** 0.25** 0.73** 0.42**
BPRS T2 0.22** 0.71** 0.41** 0.68** 0.31** 0.42** 0.31** 0.83**
Manic T1 0.36** 0.08 -0.02 0.11 0.02 0.40** 0.19**
Manic T2 0.14* 0.22** 0.12 0.12 0.09 0.49**
Anx-dep
T1
0.62** 0.07 0.10 0.12 0.20**
Anx-dep
T2
0.11 0.17* 0.18* 0.36**
Negative
T1
0.58** 0.10 0.20**
Negative
T2
0.08 0.22**
Positive
T1
0.42**
Positive
T2
T1 time 1, T2 time 2, T-Sat treatment satisfaction, BPRS brief psychiatric rating scale (mean score), Manic manic excitement, Anx-dep anxiety/
depression
* p\ 0.05, ** p\ 0.01, *** p\ 0.07,  p\ 0.09, N = 232
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296 (r = 0.16) for manic excitement, anxiety-depression and
297 positive symptoms, respectively. For each sub-syndrome
298 the interaction between time and satisfaction was insignif-
299 icant indicating that the reduction in symptoms was similar
300 for participants high or low in satisfaction, F(1,
301 230) = 2.05, 0.62, 0.40 and 0.30 (all p[ 0.05) for manic
302 excitement, anxiety-depression, negative symptoms and
303 positive symptoms, respectively. Thus, hypothesis 1 was
304 supported for manic excitement, anxiety-depression and
305 positive symptoms only. As the negative sub-syndrome was
306 unrelated to treatment satisfaction it was excluded from all
307 further analyses (Fig. 2).
308 Table 3 shows that the measurement model for each
309 sub-syndrome fitted the data reasonably well. The factor
310 loading of each indicator to its hypothesised latent factor
311 was significant providing evidence of a stable structure in
312 each group.
313 Table 4 presents the goodness of fit indices for the cross-
314 lagged panel models. Results show that for manic excite-
315 ment, neither of the cross-lagged effects was statistically
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Fig. 1 Mean scores on the sub-
syndromes during week 1 and at
1 month post-admission with
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Fig. 2 Standardised parameter estimates for the full SEM model of
treatment satisfaction and positive symptoms among patients with
psychotic disorders
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316 significant (b = 0.11 and 0.02 for the path from satisfaction
317 during week 1 to manic excitement at 1 month and from
318 manic excitement during week 1 to treatment satisfaction at
319 1 month, respectively). A similar pattern of results was
320 observed for the anxiety-depression sub-syndrome. Spe-
321 cifically, neither the path from treatment satisfaction during
322 week 1 to anxiety-depression at 1 month (b = -0.04) or
323 anxiety-depression during week 1 to treatment satisfaction
324 at 1 month (b = -0.04) were statistically significant. In
325 contrast, results for the positive sub-syndrome revealed a
326 statistically significant negative beta coefficient for the path
327 from treatment satisfaction during week 1 to positive
328 symptoms at 1 month (b = -0.15) while the path for the
329 reverse temporal ordering was negligible and insignificant
330 both in size and in statistically (b = -0.04). Supporting
331 this, the model fit indices reported in Table 4 show that the
332 cross-lagged model for the positive sub-syndrome fit the
333 data well, v2 (46, 232) = 62.13, p = 0.06, CFI = 0.99,
334 NNFI = 0.98, RMSEA = 0.04 (90% CI 0.00–0.06). Thus,
335 hypothesis 2 was supported for the positive sub-syndrome
336 only while no support for hypothesis 3 was found.
337 Discussion
338 The relationship between treatment satisfaction and psy-
339 chopathological sub-syndromes were examined among
340 involuntary in-patients in the UK with psychotic disorders.
341 With exception of the negative sub-syndrome, participants
342 reporting higher treatment satisfaction exhibited fewer
343 symptoms compared to those with lower treatment satis-
344 faction. Thus, the first hypothesis was supported for all sub-
345 syndromes except negative symptoms. The cross-lagged
346 panel analysis showed that treatment satisfaction predicted
347 change in only the positive symptom sub-syndrome pro-
348 viding support for our 2nd hypothesis. The reverse
349temporal hypothesis (hypothesis 3) was not supported for
350any of the sub-syndromes.
351The finding that treatment satisfaction relates differen-
352tially to the sub-syndromes of psychoses is new and adds to
353an increasing body of research emphasising the importance
354of examining sub-syndromes separately [33]. Indeed, dis-
355regarding different symptom dimensions may mask iso-
356lated areas of symptom change and dilute the global effect.
357A second new finding is that change in treatment satis-
358faction predicts change in scores on the positive sub-syn-
359drome, confirming the assumption that satisfaction can be
360regarded as an antecedent of positive symptoms. However,
361neither of the cross-lagged paths was significant for manic
362excitement and anxiety-depression sub-syndromes, sug-
363gesting spurious time-lagged correlations arising from
364significant concurrent associations and the stability of these
365constructs over time.
366The reasons why treatment satisfaction should influence
367change in positive symptoms versus the other sub-syn-
368dromes is unclear. However, the finding is consistent with
369previous research showing that positive symptoms may be
370more malleable and amenable to intervention [19]. In the
371current study sample, only 19% (N = 44) left hospital prior
372to the assessment at 1 month and of these, the mean length
373of stay was 19.18 days (SD = 7.04). Consequently, as
374medication adherence was involuntary and regulated
375among the majority of patients’ adherence is an unlikely
376mediator.
377While one can only speculate about the mechanisms of
378change we believe that individual difference and social
379factors may also play an important role in the relationship
380between treatment satisfaction and symptom improvement.
381For example, patients’ perceptions of autonomy may
382mediate the relationship between treatment satisfaction and
383improvement in positive symptoms. Indeed, according to
384some theories, (e.g., self determination theory) [31]
Table 3 v2 and fit indices for the measurement models
Model v2 df, N RMSEA 90% CI for RMSEA NNFI CFI
Manic excitement 63.213, p = 0.05 46, 232 0.04 0.00–0.06 0.98 0.98
Anxiety-depression 73.147, p = 0.00 44, 232 0.05 0.03–0.08 0.97 0.98
Positive symptoms 53.52, p = 0.18 45, 232 0.03 0.00–0.06 0.99 0.99
RMSEA root-mean-square error of approximation, CI confidence interval; NNFI non-normed fit index, CFI comparative fit index
Table 4 v2 and fit indices for the cross-lagged panel models
Model v2 df, N RMSEA 90% CI for RMSEA NNFI CFI
Manic excitement 80.044, p = 0.00 47, 232 0.06 0.03–0.08 0.96 0.97
Anxiety-depression 89.006, p = 0.00 46, 232 0.04 0.04–0.08 0.95 0.97
Positive symptoms 62.125, p = 0.06 46, 232 0.04 0.00–0.06 0.98 0.99
RMSEA root-mean-square error of approximation, CI confidence interval, NNFI non-normed fit index, CFI comparative fit index
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385 autonomy supportive environments (e.g., high levels of
386 perceived control among patients) have been shown to
387 facilitate motivation for treatment [5]. This speculation
388 certainly coincides with the finding that higher perceived
389 coercion among involuntary patients is linked to lower
390 levels of satisfaction with treatment [14]. Supporting this,
391 in a recent qualitative study objectification and marginali-
392 sation of the patient was identified by patients as one of key
393 themes concerning their care [28].
394 It is noteworthy that the CAT scale includes components
395 of therapeutic alliance in addition to more general aspects of
396 treatment satisfaction and it might thus be argued that these
397 constructs are synonymous. Indeed therapeutic alliance has
398 been shown to explain similar proportions of symptom
399 improvement to that found in the current study [8]. None-
400 theless, recent research has shown that although therapeutic
401 alliance and treatment satisfaction share common variance,
402 they too provide distinct information from this overlap [29].
403 However, incremental predictive validity studies including
404 both of these constructs in addition to other predictors of
405 symptom reduction, such as unmet needs for care [22] and
406 subjective quality of life [20] among psychiatric patients are
407 not widely reported thus more research is needed to ascer-
408 tain their relative importance.
409 The research reported here adds to the growing body of
410 evidence indicating that subjective patient reports are
411 predictive of important clinical outcomes. As treatment
412 satisfaction is relatively easy to elicit and could be added
413 easily to routine clinical practice these findings may have
414 considerable practical application. Nonetheless, the effect
415 size estimate between treatment satisfaction and improve-
416 ment in positive symptoms was relatively small (b =
417 -0.15). In any case the findings indicate that it may be
418 worth developing interventions to enhance treatment sat-
419 isfaction. If such interventions could be developed and
420 were found to be effective, they might also shed further
421 theoretical light on the psychological antecedents of posi-
422 tive symptoms, e.g., by identifying moderators and medi-
423 ators of treatment re-training effectiveness. This could also
424 facilitate assessment of the potential risks, gains and cost
425 effectiveness of such interventions and therefore assess-
426 ment of their practical utility.
427 The use of latent variable SEM allowed examination of
428 relationships between constructs with measures that were
429 relatively free of measurement error. Additionally, the
430 sample size was large and comprised a relatively large and
431 diagnostically homogeneous sample. Moreover, the use of
432 researcher-rated rather than self-reported outcomes reduced
433 the likelihood of artificially inflating effect size estimates
434 resulting from common method variance. Nonetheless,
435 data were only available for those patients willing to take
436 part in academic research which may have introduced a
437 selection bias. Also, although the sample size is impressive
438for this particular group of patients the large number
439required for statistical modelling meant that examination of
440each item individually to its respective factor was not
441feasible in the SEM. This is important, as while the CAT
442items have good face validity and predictive utility, in
443addition to high internal consistency reliability [26], the
444factorial validity of the CAT is yet to be established.
445To test the generalisability of the study findings, future
446research is needed to replicate the current findings in
447samples with different diagnoses and for patients in dif-
448ferent treatment settings. Moreover, theory-based research
449could help to locate the specific mechanisms that lead to
450change in positive symptoms. For these purposes, future
451studies could test psychological theories (such as self-
452determination theory) which provide a theoretical frame-
453work for exploring these relationships.
454Understandably, clinicians might think that immediate
455patient satisfaction is not that relevant among patients
456compulsory admitted. However, this study emphasises that
457what patients think about their care within the first week of
458treatment is an indicator of changes in positive symptoms
459at 1 month post-admission and thus, could be considered
460even when symptom levels are often still high and the
461situation tense.
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